Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
IMMUDEX ApS
APS
Active
CVR 31348854
Bredevej 2A, 2830
Virum
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2008 · 18 years old
39 employees
www.immudex.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
IMMUDEX ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
37M
28M
19M
9M
0M
2021: 24M
24M
2021
2022: 19M (-21% vs 2021)
19M
-21%
2022
2023: 30M (+58% vs 2022)
30M
+58%
2023
2024: 25M (-17% vs 2023)
25M
-17%
2024
2025: 23M (-8% vs 2024)
23M
-8%
2025
EBITDA
DKK millions
6M
1M
-4M
-8M
-13M
2021: 2M
2M
2021
2022: -9M (-550% vs 2021)
-9M
-550%
2022
2023: 0M (+100% vs 2022)
0M
+100%
2023
2024: -8M
-8M
2024
2025: -9M (-12% vs 2024)
-9M
-12%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
22.665
25.173
29.872
18.938
24.389
Staff expenses
-31.671
-33.091
-29.836
-27.971
-22.616
EBITDA
-9.006
-7.918
36
-9.034
1.774
Depreciation & amort.
-1.982
-1.694
-1.525
-1.476
-1.076
EBIT
-10.988
-9.612
-1.489
-10.509
698
Net financials
-2.148
514
-708
2.540
-548
Profit before tax
-13.136
-9.098
-1.368
-9.187
49
Tax
-2.110
-1.992
-276
-2.418
-706
Net profit
-11.025
-7.106
-1.092
-6.769
754
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
49.096
46.587
42.449
41.060
46.841
Equity
16.050
24.947
29.924
29.376
34.451
Long-term debt
3.811
4.049
4.360
4.433
4.624
Short-term debt
29.235
17.591
8.165
7.251
7.766
Total debt
33.046
21.640
12.525
11.685
12.389
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-39,7 %
This company
2021
2025
Equity ratio
32,7 %
This company
38,2 %
Market median
This company
Market median
14% below market
2021
2025
Return on equity
-68,7 %
This company
18,4 %
Market median
This company
Market median
473% below market
2021
2025
Net profit margin (of gross profit)
-48,6 %
This company
2021
2025
Asset turnover (of gross profit)
0,46×
This company
2021
2025
Debt / equity
2,06×
This company
0,62×
Market median
This company
Market median
232% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
More on IMMUDEX ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
